Multi-omics data integration — combining genomics, transcriptomics, proteomics, metabolomics, and clinical phenotype data into a unified analytical framework — is the technical foundation of precision medicine drug discovery. The data is increasingly available: whole exome and genome sequencing is now routine in clinical trials, proteomics platforms can measure thousands of proteins in biological fluids, and electronic health record linkage provides the clinical phenotype context. The bottleneck is no longer data generation — it is semantic integration.
The Heterogeneity Problem
Each omic data modality uses its own identifier system, its own measurement conventions, and its own reference databases. Genomic variants are identified by chromosomal position or rsID; genes by Ensembl, Entrez, or HGNC identifiers; proteins by UniProt accession; metabolites by HMDB or ChEBI identifiers; clinical phenotypes by SNOMED CT, ICD, or HPO terms. A semantic integration layer must formally map each of these identifier systems to a shared reference ontology, so that a genetic association between a variant and a clinical phenotype, a protein abundance change associated with that variant, and a drug mechanism targeting the protein encoded by the affected gene can all be queried together — even though they originate from completely different data systems.
The Semantic Integration Architecture
A practical multi-omics semantic integration architecture uses a knowledge graph as the integration hub. Each omic data source contributes typed assertions to the graph: gene-variant associations from the genomics layer, gene-protein relationships from the proteomics layer, gene expression patterns from the transcriptomics layer, and phenotype associations from the clinical data layer. The ontological identifiers serve as the joins between layers — a gene node in the knowledge graph connects to its associated variants, its protein product, its expression patterns, and the clinical phenotypes with which it is associated. Multi-hop graph queries then traverse these connections to generate testable biological hypotheses.
Quality and Confidence Management
Multi-omics knowledge graphs are only as valuable as the quality and confidence scoring of the assertions they contain. Genomic associations from large-scale GWAS carry different confidence levels than associations from small candidate gene studies. Protein-protein interaction data from high-throughput screens carries different reliability than data from targeted biochemical experiments. Each assertion must carry a provenance record and a confidence score, and multi-hop queries must propagate confidence through the reasoning chain so that conclusions resting on multiple low-confidence assertions are appropriately discounted relative to those supported by high-quality direct evidence.
